tirzepatide serena williams is returning to tennis — and bringing the GLP-1 debate with her 🎉 Serena Williams is celebrating

Clinical trials have shown that patients can lose up to half of their excess weight with these medications

Days 2 and 3: side effects peak (if they come at all) If you are going to experience gastrointestinal side effects from your first dose, days two and three are when they most commonly appear

Common eligibility criteria may include: BMI of 30 or higher BMI of 27 or higher with at least one weight-related health condition History of failed diet attempts or weight regain Appetite, cravings, or portion control challenges Metabolic risk factors such as insulin resistance, elevated glucose, high cholesterol, or hypertension Need for physician-supervised weight loss due to medical complexity Eligibility must be determined through a medical consultation

Empowering Patients through Comprehensive Education Informed consent is more than a legal requirement

Since it was deemed unethical to treat people with established cardiovascular disease (CVD) and type 2 diabetes (who are at high risk of future cardiovascular events) with placebo, the present study, SURPASS-CVOT, was the first cardiovascular outcomes trial to use an active comparator: in this case, dulaglutide 1.5 mg weekly, which had previously been proven to have cardiovascular benefit in the REWIND trial (Gerstein et al, 2019)